- Press Release -

Rockville, Md. The global market for OTC herbal and traditional medicines is set to surpass US$ 30 Bn by 2022, growing at a 4.8% CAGR, according to Fact.MR. As worries about the side effects of synthetic drugs mount, more consumers are turning to herbal and traditional systems, opening room for manufacturers even as safety and quality questions keep the category under scrutiny.

Asia Pacific excluding Japan dominates, digestive-health products lead by function, and powdered forms are the preferred dosage. A broader cultural shift toward Yoga, Unani and Ayurveda, tracked by the Ministry of AYUSH, is helping carry demand forward.

Functions, Channels and Dosage

Digestive-health products hold the largest revenue by function, while bone and joint health and nutrition grow at similar rates, with nutrition the larger of the two. By channel, modern trade is the preferred route, online sales grow fastest, and pharmacies keep a larger share but expand slowly. On dosage, powdered forms lead and are set to exceed US$ 10 Bn by 2022, tablets outsell liquids, and liquids grow at the quicker pace.

Asia Pacific excluding Japan stays dominant through 2022, North America holds second place, and Japan remains the least lucrative market.

Safety and Tradition Shape Growth

The market sits at an interesting crossroads. Herbal and traditional medicines carry valuable ingredients but can also include harmful ones, which has pushed regulators and research bodies such as AYUSH and the Dabur Research and Development Center toward tighter quality checks and, in some cases, physician oversight. That scrutiny, alongside renewed interest in traditional systems, is reshaping how the category is made and sold.

Suppliers and Their Playbook

The field spans global nutrition brands and specialist herbal makers.

• Amway Corporation, Phytomed Herbal Solutions, Herbalife International, Biovontrade SARL, The Himalayan Drug Company, Nutra Green Biotechnology Co., Ltd., Naturex SA, Bio-Botanica, Inc., Nutraceutical International Corporation, The Nature's Bounty Co., Medico Herbs, The Bioforce Group, Jiaherb Inc., Ricola AG, Dabur India Ltd., Bionorica SE, Blackmores Limited, and Integria Healthcare Pty Ltd. are among the key players in the report.

Reading the Market for Decisions

For manufacturers, growth favours digestive-health and powdered products, backed by modern-trade and online distribution. Investors get a market with steady, culturally rooted demand. Procurement and retail teams can plan around modern trade leading sales and Asia Pacific carrying the largest opportunity through 2022.

About the Report

Fact.MR's study covers the global OTC herbal and traditional medicines market for the 2017 to 2022 forecast period, with segmentation by function, OTC channel, dosage and region. It sizes each segment, maps the competitive field, and weighs the consumer and regulatory forces shaping demand. Further detail is available in the OTC herbal and traditional medicines market report.

About Fact.MR

Fact.MR is a market research and consulting agency with deep expertise in emerging market intelligence. The firm is known for its syndicated research, custom research and consulting solutions, helping clients make decisions on demand, competition, investment, procurement and future growth.